IFC and Estonia, Latvia, Lithuania, Partners in Private Sector Development

doi:https://doi.org/10.1596/41236

Publication:
IFC and Estonia, Latvia, Lithuania, Partners in Private Sector Development

dc.contributor.author	International Finance Corporation
dc.date.accessioned	2024-03-20T17:44:43Z
dc.date.available	2024-03-20T17:44:43Z
dc.date.issued	2023-09-01
dc.description.abstract	IFC maintains a focused relationship with the Baltic countries, which revolves around engagement with select companies in the fintech and tech, forestry, logistics, agribusiness and retail sectors, which are interested in co-investment opportunities in emerging markets. As of June 2023, IFC had a long-term committed investment portfolio of twenty-five million with Estonian partners in the Disruptive Technologies and Funds sector. In February 2023, IFC, the Association of the Latvian Chemical and Pharmaceutical Industry (LAKIFA) and MIGA organized an online workshop on investment opportunities in the health sector. In September 2022, IFC and MIGA held a business development event focused on the Disruptive Technologies and Funds sector with the Lithuanian Innovation Agency and the Ministry of Finance.	en
dc.identifier	http://documents.worldbank.org/curated/en/099421003122439634/IDU1da62168217c181430c188d41d6bec2766d53
dc.identifier.doi	10.1596/41236
dc.identifier.uri	https://hdl.handle.net/10986/41236
dc.language	English
dc.language.iso	en_US
dc.publisher	Washington, DC: World Bank
dc.rights	CC BY-NC-ND 3.0 IGO
dc.rights.holder	World Bank
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/3.0/igo/
dc.subject	CHEMICAL ENGINEERING
dc.subject	PRIVATE EQUITY FUNDS
dc.subject	PHARMACEUTICAL AVAILABILITY
dc.subject	HEALTH SYSTEMS GOVERNANCE AND REGULATORY
dc.title	IFC and Estonia, Latvia, Lithuania, Partners in Private Sector Development	en
dc.type	Brief
dspace.entity.type	Publication
okr.date.disclosure	2024-03-12
okr.date.lastmodified	2024-03-12T00:00:00Z	en
okr.doctype	Brief
okr.doctype	Publications & Research
okr.docurl	http://documents.worldbank.org/curated/en/099421003122439634/IDU1da62168217c181430c188d41d6bec2766d53
okr.guid	099421003122439634
okr.identifier.docmid	IDU-da621682-7c18-430c-88d4-d6bec2766d53
okr.identifier.doi	https://doi.org/10.1596/41236
okr.identifier.externaldocumentum	34279334
okr.identifier.internaldocumentum	34279334
okr.identifier.report	188280
okr.import.id	3517
okr.imported	true	en
okr.language.supported	en
okr.pdfurl	http://documents.worldbank.org/curated/en/099421003122439634/pdf/IDU1da62168217c181430c188d41d6bec2766d53.pdf	en
okr.region.country	Europe
okr.topic	Industry::Chemical & Petrochemical Industry
okr.topic	Health, Nutrition and Population::Pharmaceuticals & Pharmacoeconomics
okr.topic	Health, Nutrition and Population::Health Systems Development & Reform
okr.unit	Western Europe Regional Dept (CWEDR)